Enteral Feeding Devices Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global enteral feeding devices market size was valued at USD 6.5 billion in 2024 and is expected to exhibit growth at a CAGR of 5.9% from 2025 to 2034 period. The market growth is attributed to the rising prevalence of chronic diseases, increase in demand for neonatal and preterm enteral feeding, surging preference for enteral feeding at home care settings, contributing to their growing adoption.
Chronic illnesses including cancer, neurological disorders, and gastrointestinal diseases, often hinder patients ability to consume food orally. This makes enteral feeding devices crucial for ensuring adequate nutrition and enhancing health outcomes. In oncology, particularly for cancers of the head, neck, or gastrointestinal tract, enteral feeding devices are extensively utilized to provide nutrition during and after cancer treatments, significantly contributing to patient recovery and quality of life.
Enteral feeding devices are used to deliver nutrition directly into the gastrointestinal tract. They include various components like tubes, pumps, and syringes, designed to ensure patients receive adequate nutrients when oral intake is insufficient or impossible.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Enteral Feeding Devices Market size in 2024: | USD 6.5 Billion |
Forecast Period: | 2025 – 2034 |
Forecast Period 2023 - 2032 CAGR: | 5.9 |
2023 Value Projection: | USD 11.6 Billion |
Historical Data for: | 2021 – 2024 |
No of Pages: | 140 |
Tables, Charts & Figures: | 283 |
Segments Covered: | Product, Patient, Application, End Use, Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Technological advancements are playing a pivotal role in driving the growth of the market by enhancing device functionality, safety, and ease of use. These innovations address critical challenges in enteral nutrition, such as patient comfort, infection prevention, and seamless nutrient delivery.
Based on product, the market is segmented as enteral feeding tubes, enteral feeding pumps, enteral syringes, giving sets, and accessories. The enteral feeding tubes segment is expected to drive business growth and expand at a CAGR of 5.6%, reaching over USD 4.7 billion by 2034.
Based on patient, the enteral feeding devices market is segmented as adult and pediatric. The adult segment dominated the market and is expected to grow at a pace of 5.4% CAGR between 2025 and 2034.
Based on application, the enteral feeding devices market is segmented as cancer, central nervous system (CNS) and mental health, non-malignant gastrointestinal (GI) disorders, and other applications. The cancer segment dominated the market in 2024 with a market share of 47.3%.
Based on end use, the market is segmented as home care, hospitals, and other end users. The home care segment dominated the market in 2024 and is anticipated to reach USD 5.7 billion by the end of the forecast period.
The U.S. enteral feeding devices market accounted for USD 1.9 billion in 2024 and is anticipated to grow at a CAGR of 5.2% between 2025 to 2034 period.
France enteral feeding devices market is projected to grow remarkably in the coming years.
Japan holds a dominant position in the Asia Pacific enteral feeding devices market.
Several key players in the market are making strides in type innovation and strategic partnerships to maintain market leadership. Companies are investing heavily in R&D to develop advanced enteral feeding devices with enhanced features such as the integration of feeding devices with digital monitoring systems, enhanced placement techniques, and development of smart feeding pumps.
Additionally, partnerships with healthcare providers are being forged to improve type accessibility in emerging markets. Regulatory compliance and adherence to international quality standards are crucial aspects of the strategies employed by these companies to cater to a global market. These developments are helping companies meet the increasing demand for safe and efficient enteral feeding devices.
Prominent players operating in the enteral feeding devices industry include:
Market, By Product
Market, By Patient
Market, By Application
Market, By End Use
The above information is provided for the following regions and countries:
Key players in the market include ALCOR SCIENTIFIC, Abbott, AMSINO, AMT, B Braun, Baxter, Becton Dickinson, Boston Scientific, Cardinal Health, CONMED, Cook Medical, DANONE, and FRESENIUS KABI.
The U.S. enteral feeding devices market was valued at USD 1.9 billion in 2024 and is expected to grow at a 5.2% CAGR from 2025 to 2034, supported by an aging population and the growing adoption of home healthcare solutions.
The global enteral feeding devices industry was valued at USD 6.5 billion in 2024 and is projected to grow at a 5.9% CAGR from 2025 to 2034, driven by the increasing prevalence of chronic diseases and rising demand for home care solutions.
The cancer segment led the market in 2024, holding a 47.3% share, as these devices ensure uninterrupted nutrition during cancer treatments, aiding recovery and reducing complications.